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ONIZED calcium regulates many cellular processes, such as cell motility, muscle contraction, axonal flow, cytoplasmic streaming, neurotransmitter release, endocytosis, andexocytosis. Intracellular Ca 2+ concentrations under steady state conditions are low, usually below 10" 7 M. Upon stimulation, the Ca 2+ concentration increases transiently and apparently signals an appropriate response, which is often mediated by Ca 2+ -binding proteins, of which the most ubiquitous is calmodulin. Calmodulin binds Ca 2+ in the presence of physiological concentrations of Mg 2+ (10~3 M), resulting in a conformational change that allows it to activate any of a number of enzymes. Many drugs, including some organic Ca 2+ channel blockers, bind to the active form of calmodulin and antagonize its activity in vitro.
This commentary addresses the question of whether calmodulin plays a role in the actions of certain Ca 2+ channel blockers. As background information, a brief description of the salient features of calmodulin is presented.
nicotinamide adenine dinucleotide (NAD) metabolism (NAD kinase), cross-linking of (y-glutamyl)-e-lysine bonds in proteins (transglutaminase 4 ), and the synthesis and release of neurotransmitters (calmodulin-dependent protein kinases and protein phosphatase; for general reviews, see References 5 and 6). Since phosphorylation and dephosphorylation of proteins play a key role in regulating many cellular processes, 7 the potential importance of calmodulin-dependent protein kinases and protein phosphatase (both enzymes appear to be multifunctional) goes beyond their involvement in neurotransmission. In all of these cases, the effect of calmodulin is to activate the target enzyme. In the absence of Ca 2+ , calmodulin is inactive; when the intracellular Ca 2+ concentration is increased to 10~6 or higher in response to an appropriate stimulus, calmodulin binds Ca 2+ and assumes a more helical conformation, 8 with exposure of a hydrophobic patch on its surface that is believed to interact with a target enzyme to form an activated holoenzyme. 9 ' 10 The mechanism of action of calmodulin (CaM) can be outlined as a two-step, reversible process:
xvt ---Ca 2+ •CaM*-enzyme* Ktivc (2) In the first step (Equation 1), up to four Ca 2+ ions are bound to calmodulin, which assumes a new conformation (indicated by the asterisk). In the second step (Equation 2), the Ca 2+ -activated calmodulin binds to a target enzyme, causing an increase in the V^ of the enzyme with little effect on the K m for the substrate. The activated enzyme is also believed to assume a new conformation. When the concentration of Ca 2+ decreases to a steady state level, calmodulin dissociates and the enzyme returns to its basal activity level. The activated conformation of calmodulin binds phenothiazines and some calcium channel blockers in.vitro. When bound to calmodulin, such compounds prevent the protein from interacting with its target enzyme and thus act as a calmodulin antagonist.
Calmodulin is found in the cytoplasm and in paniculate structures, including the mitotic apparatus." How-218 HYPERTENSION VOL 9, No 3, MARCH 1987 ever, its role in mitosis is not fully understood. Besides the calmodulin-dependent enzymes referred to above, calmodulin binds, in a Ca 2+ -dependent manner, a number of other proteins, and they may well be additional calmodulin-dependent enzymes. 12 Some of the calmodulin-binding proteins are associated with die cytoskeleton (e.g., fodrin and caldesmon), and the importance of these associations remains unclear.
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Structure of Calmodulin
As might be expected of a multifunctional protein, the amino acid sequence of calmodulin is highly conserved; for example, human brain calmodulin differs in one amino acid residue from eel electroplax calmodulin. 16 The amino acid sequence of bovine brain calmodulin consists of 148 residues and is schematically depicted in Figure 1 . The molecule (M r 16,700) contains some 30% acidic amino acids and no tryptophan, hydroxyproline, or cysteine; the lack of these residues allows the protein to be stable and flexible. 18 The calmodulin genes in chicken and eel have been cloned, and their nucleotide sequences show striking similarity to genes for other Ca 2+ -binding proteins. 16 The complete structure of calmodulin appears to be needed for its biological activity. In general, proteolytic or chemically generated peptides of calmodulin are virtually inactive. 6 The three-dimensional structure of bovine testis calmodulin has recently been determined crystallographically at 3.0 A resolution. 19 The protein consists of two globular lobes connected by an a-helix; each lobe binds two Ca 2+ ions, and the overall structure assumes a dumbbell appearance ( Figure 2 ). (In this study, calmodulin was crystallized at pH 5.6. It is not known whether at a physiological pH of 7.2-7.3 calmodulin assumes such a tertiary structure). Studies by differential kinetic labeling 20 suggest that on binding Ca 2+ the central helix of calmodulin becomes more exposed and that /3-endorphin, a calmodulin-binding peptide, interacts with this region and the carboxyterminus. Other studies indicate that hydrophobic interaction is important in the complex formation between calmodulin and peptides.
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Calmodulin and Smooth Muscle Contraction
Although calmodulin is ubiquitous and activates a wide spectrum of enzymes, the role of myosin light chain kinase (MLCK) in smooth muscle contraction is one of a few processes in which a physiological role for calmodulin has been demonstrated. This section will briefly discuss the role of calmodulin and myosin light chain kinase in smooth muscle contraction.
MLCK has been purified from smooth, cardiac, and skeletal muscles, as well as other tissues. The enzyme from chicken gizzard has an apparent molecular weight of 130,000, whereas enzymes from bovine stomach and trachea have molecular weights of 155,000 and 150,000, respectively. 23 Gizzard smooth muscle MLCK has been localized in actin microfilament bundles. 24 Skeletal muscle MLCK is found in the I band, where it may be involved in posttetanic potentiation of action potential. 23 In smooth muscle, calmodulin activates MLCK, which in turn phosphorylates serine-19 of myosin light chain, a 20-kDa subunit of myosin. Phosphorylation allows the interaction between myosin and actin, and the stimulation of myosin ATPase, leading to contraction of the actomyosin filament. MLCK from chicken gizzard depends absolutely on calmodulin and Ca 2+ for activity. The enzyme displays high affinity for calmodulin (K d -10~9 M), and the stoichiometry of the calmodulin-MLCK complex is 1:1, 26 The kinase is highly specific for the myosin light chain, with little or no activity toward other proteins. 27 MLCK can itself be phosphorylated by cyclic adenosine 3',5'-monophosphate (cAMP)-dependent protein kinase, leading to a 10-fold to 20-fold decrease in its affinity for calmodulin. 28 This may account for the observation that catecholamines, which stimulate adenylate cyclase to generate cAMP, relax vascular muscle.
Blumenthal et al. 29 identified a peptide fragment of 219 skeletal muscle MLCK that binds calmodulin with the same affinity as the native enzyme. They also synthesized a peptide corresponding to a 27-residue fragment of MLCK; the peptide is basic and binds even more tightly {K A < 10" 10 M) to calmodulin than does the intact enzyme. These results imply that the calmodulinbinding domain of MLCK is relatively small.
The phosphorylation of myosin light chain is closely correlated with the development of tension in smooth muscle. In chemically skinned smooth muscle cells from pulmonary arteries, the tension that developed in the presence of Ca 2+ and adenosine 5'-triphosphate (ATP) correlated positively with the extent of the phosphorylation of myosin light chain. 30 Pretreatment of the smooth muscle cells with trifluoperazine (a calmodulin antagonist; see next section) prevented the development of tension. Replacing ATP with adenosine 5'-diphosphate (ADP)-S-P to thiophosphorylate myosin results in a prolonged tension, apparently because the thiophosphorylated protein is not easily dephosphorylated. A temporal relationship also exists between the development of force in intact carotid artery and phosphorylation of myosin light chain. 31 Moreover, dephosphorylation of the myosin light chain appears to precede relaxation. Further evidence for a calmodulin-dependent contraction of smooth muscle comes from experiments in which phenothiazine caused relaxation of aortic smooth muscle that had been contracted by K + , Ca 2+ , norepinephrine, histamine, or prostaglandin F^. 32 Although phenothiazine relaxes smooth muscle cells under these conditions, there is no evidence that it can be used successfully to treat hypertension.
Calmodulin Antagonists
A number of hydrophobic drugs, particularly the phenothiazines and the naphthalenesulfonamides, bind tightly to calmodulin (K A in the micromolar range) in the presence of Ca 2+ . 3334 The interaction is much weaker in the absence of Ca 2+ , suggesting that in the presence of Ca 2+ the drugs bind to the Ca 2+ -induced hydrophobic site(s) of calmodulin.
9 ' 10 The hydrophobic nature of the interaction can be inferred from the reported correlation between the hydrophobicity of the drugs, as measured by octanol-water partition coefficients, and the affinity for calmodulin. 35 The Ca 2+ -specific interaction between calmodulin and phenothiazines has been exploited to devise an effective affinity column for the purification of calmodulin. 36 ' 37 Cross-linking experiments 38 have localized three phenothiazine binding sites on calmodulin: one near the middle (residues 38-75) and two toward the carboxyterminal end (residues 107-126 and 127-148). A complete tertiary structure of calmodulin appears to be required for effective binding of the phenothiazines; various fragments of calmodulin (amino acid residues 1-90, 1-37, and 107-148) do not interact significantly with the phenothiazines. 39 Other investigators, 40 though they are effective antagonists of calmodulin in vitro, their psychoactive potencies do not correlate with their affinities for calmodulin. For example, both the cis and trans isomers of flupentixol bind to calmodulin with comparable affinity, but only the cis form is biologically active. 44 The phenothiazines are not specific for calmodulin; they bind to a-adrenergic receptors, protein kinase C, S-100, and troponin C. 35 Many other drugs, such as minor tranquilizers (e.g., chlordiazepoxide), antidepressants (e.g., amitriptyline), local anesthetics (e.g., dibucaine), and some Ca 2+ channel blockers (e.g., felodipine) bind to calmodulin and antagonize its activity in vitro, albeit to a lesser extent. All of these pharmacological agents are amphipathic, that is, they are both hydrophobic and cationic. Certain synthetic peptides, 21 peptide hormones, 45 and the insect venom peptides melittin and mastoparan are amphipathic and bind to calmodulin in a Ca 2+ -dependent manner.
4 *' 47 It is prudent to examine whether the in vitro anticalmodulin activity of an agent is indeed related to its pharmacological action.
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2+ Channels and Ca 2+ Channel Blockers
The steady state intracellular concentration of Ca 2+ is usually between 10~8 and 10~7 M, several orders of magnitude lower than the millimolar concentration in the extracellular fluid. A small amount of Ca 2+ can leak into the cell, but most Ca 2+ is brought in through a slow inward Ca 2+ channel. During stimulation, the Ca 2+ channel is opened transiently, allowing an influx of Ca 2+ . Na + also enters the cell, but through a Na + channel. 48 Whereas Na + influx is a rapid, early event, mediated by a fast Na + channel, the Ca 2+ inward current develops after the Na + current, showing slower rates of activation and inactivation. 49 In 1967, Fleckenstein et al. 50 demonstrated that prenylamine and verapamil mimic the effect of Ca 220 HYPERTENSION VOL 9, No 3, MARCH 1987 removal from the medium of cardiac cells in vitro. The Ca 2+ channel blockers are structurally and pharmacologically diverse, and Murphy et al. 51 have classified them into four groups: 1) dihydropyridines (such as nifedipine and nitrendipine), 2) phenylalkylamines (such as verapamil and methoxyverapamil (D600), 3) benzothiazepines (such as diltiazem), and 4) diphenylalkylamines (such as lidoflazine and prenylamine). The various classes of Ca 2+ channel blockers produce different effects in vascular and cardiac tissue. Phenylalkylamines and benzothiazepines are approximately equiactive in cardiac and smooth muscle, whereas the dihydropyridines are significantly more active in vascular and nonvascular smooth muscle. 49 Within each class of Ca 2+ channel blockers, especially the dihydropyridines, there are defined structure-activity relationships, including stereoselectivity. 52 " For example, [
3 H]nitrendipine exhibits reversible, saturable, highaffinity (K i = \0~9 M) binding to smooth and cardiac muscle membranes. 54 Among a series of 1,4-dihydropyridines, there was good correlation between binding affinities and pharmacological effects. 55 Tissues show qualitative and quantitative differences in their Ca 2+ channels. Brain has been shown by autoradiography with [ 3 H]nitrendipine to have a high density of binding sites in synapses and a low density in the blood vessels. Yet the pharmacological and in vitro effects of the Ca 2+ channel blockers are most pronounced in smooth and cardiac muscle. The difference in tissue response of Ca 2+ channels to membrane potential change and to receptor stimulation are particularly striking. In rabbit aorta, the K + -induced change (which modulates transmembrane potential) was 10 times more sensitive to diltiazem than the norepinephrine-induced change (which is mediated by specific receptors). In contrast, the norepinephrineinduced contraction in rabbit mesenteric resistance vessel was more sensitive than the K + -induced response. 57 Differences in sensitivity between potentialoperated and receptor-operated channels have been noted in a variety of other tissues and species. 49 The site of action of the channel blockers appears to be the potential-operated or receptor-operated channels in the plasma membrane on the cytoplasmic face. Smooth muscle cells lacking their plasma membrane appear not to be inhibited by channel blockers, and the drug D890, a quaternary ammonium derivative of methoxyverapamil that does not cross the plasma membrane, has no effect on smooth muscle tension when used at concentrations 10-fold higher than that of the parent compound. However, when injected directly into cells, D890 produces the same effect as D600 at a comparable concentration. 5 * Although the Ca 2+ channels are voltage-sensitive and are opened by depolarization of the cell, the extent to which Ca 2+ channels are influenced by receptor-mediated events (such as the action of epinephrine, histamine, and serotonin) is still controversial.
The slow inward Ca 2+ channel is apparently an integral membrane glycoprotein. An affinity-labeled analogue of nifedipine interacted with a 45-kDa polypeptide 59 and inhibited the activity of the Ca 2+ channels of smooth muscle membranes of guinea pig ileum. A high-affinity receptor for nifedipine has been partially purified from transverse tubule membranes of skeletal muscle. 60 The receptor is associated with a glycoprotein consisting of three polypeptides with molecular weights of 130,000 (a-subunit), 50,000 Q3-subunit), and 33,000 (y-subunit). The /3-subunit may be similar to the 45-kDa polypeptide found in the guinea pig ileum. 59 Radiation inactivation analysis indicates that the Ca 2+ channel from smooth muscle has a molecular weight of 278,000, whereas that from skeletal muscle transverse tubules has a molecular weight of 210.000.
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The Ca 2+ channel blockers recognize distinct sites on the channel oligomer, which appears to consist of at least three separate, allosterically linked sites for the different classes of channel blocker. The three sites copurify and probably are located on the same macromolecular complex. 62 The most extensively characterized site is the dihydropyridine binding site: binding at this site by nifedipine and nitrendipine inhibits the channel, 63 whereas binding by (-)Bay k 8644 (methyl-1,4-dihydro-2,6-dimethyl-3-nitro-4-[2-trifluoromethyl-phenyl]-pyridine-5-carboxylate) or ( + )202-791 (both are dihydropyridine derivatives) stimulate it, provided that the channel has been opened by depolarization. 6465 The second site binds benzodiazepines, and the third site binds phenylalkylamines. Binding at either of these sites can inhibit or stimulate binding at the dihydropyridine site through allosteric interactions. For example, binding of nitrendipine to the first site is stimulated by diltiazem 51 ; and inhibited by verapamil. 62 Conversely, binding of ( + )PN 200-110 (another dihydropyridine derivative) at the first site inhibits the binding of (-)desmethoxyverapamil (a phenylalkylamine) at the third site. 66 The third site, which binds phenylalkylamines with high affinity, is associated with open channels. This may explain the observation that verapamil is more effective with a fast-beating heart (which has a greater proportion of open channels) than with a normal one. 67 The second site, which binds benzothiazepines with high affinity, also binds phenylalkylamines with low affinity.
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Calmodulin and Ca 2+ Channel Blockers
Several Ca 2+ channel blockers, including felodipine, 69 
"
71 prenylamine, 72 bepridil, and flunarizine, 73 interact with calmodulin in vitro. With the exception of bepridil, the concentration at which the channel blockers half-maximally inhibit calmodulin activity is micromolar, some 1000-fold greater than their phar-macologically effective concentrations for blocking smooth muscle contraction in vitro. The interaction of nifedipine and nicardepine (a related dihydropyridine) with calmodulin is of low affinity, unsaturable, and at a site distinct from that for phenothiazines. 74 Agre et al. 73 reported that bepridil and cetiedil, two channel blockers resembling diltiazem in structure and action, inhibited the binding of labeled calmodulin to erythrocyte membranes as well as the calmodulin-dependent activation of erythrocyte membrane Ca 2+ -ATPase. They believe that bepridil and cetiedil exert their pharmacological effects by interacting with calmodulin rather than with the Ca 2+ channels. In their studies, 10 /i.M bepridil inhibited the Ca 2+ -ATPase by 50%. On the other hand, Vogel et al. 76 showed that 0.5 IxM. bepridil rapidly depressed the contraction of an isolated, perfused guinea pig heart and that the effect of bepridil was neutralized by 2 to 4 mM Ca 2+ . Such a reversal by Ca 2+ is characteristic of organic Ca 2+ blockers; the effect of a calmodulin antagonist usually is not reversed by the addition of Ca 2+ . Vogel et al. 76 further noted that bepridil completely abolished muscle contraction without affecting the slow action potential. They concluded that there could be a second site for bepridil action, such as the release of Ca 2+ from the sarcoplasmic reticulum.
Several drugs appear to act as both Ca 2+ channel blockers and calmodulin antagonists. The phenothiazines thioridazine and mesoridazine allosterically regulate the Ca 2+ channel (they enhance [ 3 H]nitrendipine binding to smooth muscle membranes) in the same fashion as diltiazem, but at concentrations approximately 10-fold to 100-fold higher. 51 Thioridazine and mesoridazine, which are also calmodulin antagonists, inhibited ejaculation and possibly, contraction of smooth muscle of vas deferens 77 at about 2 /xM, a concentration much higher than that required by conventional Ca 2+ channel blockers to inhibit smooth muscle contraction.
Concluding Remarks
Calmodulin is ubiquitous among mammalian tissues but is not found in highly purified membrane proteins that show a high-affinity binding for Ca 2+ channel blockers. The tissue specificity of the Ca 2+ channel blockers compared with the ubiquitous distribution of calmodulin appears to make it unlikely that calmodulin is a primary target of Ca 2+ channel blockers in smooth muscle and myocardial cells. Phenothiazines antagonize calmodulin activity in vitro but do not block the Ca 2+ channel, whereas most channel blockers interact much more strongly with the Ca 2+ channel than with calmodulin. Calcium channel blockers and phenothiazines are both amphipathic; they may interact with calmodulin nonspecifically.
Protein kinase C appears to phosphorylate the Ca 2+ channel, resulting in either stimulation 78 or inhibition. 79 - 80 Still virtually unexplored is the possibility that the Ca 2+ channel may be modulated by a calmodulin-dependent protein kinase or phosphatase. 81 However, no clear evidence appears for a direct role of calmodulin in the pharmacological effects of Ca 2+ channel blockers, and more work is necessary before its role can be clarified.
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